NASDAQ:INSM

Insmed Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$26.18

+0.0300 (+0.115%)

At Close: Apr 17, 2024

Currently predicting for Fri, 19 Apr 2024

Trading levels for INSM

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	26.88	2.67 %
		R2	26.62	1.67 %
		R1	26.45	1.04 %
Current price:			26.18
	Support	S1	25.93	-0.97 %
		S2	25.76	-1.59 %
		S3	25.50	-2.60 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	28.75	9.82 %
		R2	27.80	6.19 %
		R1	27.28	4.20 %
Current price			26.18
	Support	S1	26.15	-0.115%
		S2	26.14	-0.153%
		S3	25.72	-1.76%

INSM Predictions History

4 years ago
Lennon Pierce predicted that INSM for 2020-01-09 is going $26.70 (3.45%)

Rank:

4 years ago
GoldenNugget predicted that INSM for 2019-05-07 is going $31.10 (-3.40%)

4 years ago
NameNotImportant predicted that INSM for 2019-05-06 is going $30.44 (-3.15%)

4 years ago
NameNotImportant predicted that INSM for 2019-05-02 is going $28.74 (-3.33%)

About Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Golden Star

Ticker	Date	Change	Price
ITCI	Apr 05	12.05%	$68.44
AKR	Apr 05	0.665%	$16.53
SARK	Mar 28	16.07%	$26.88
ARCC	Mar 25	1.04%	$20.12
STT	Mar 19	0.262%	$72.62
GGB	Mar 19	0.468%	$4.27
CAG	Mar 18	7.16%	$28.22
JBI	Mar 15	1.29%	$14.72
MASI	Mar 14	3.34%	$132.20
CMC	Mar 14	5.04%	$53.19

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In